Received Mar 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
innapropriate age of vaccine administered; HCP states she could not confirm if there were any symptomatic events that occurred; This spontaneous report has been received from a health care proffesional regarding a 11-months-old patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant therapies was not reported. On an unspecified date (reported as one day before their first birthday), the patient was vaccinated with Varicella Virus Vaccine Live (Oka-Merck) lyophilisate and solvent for solution for injection (VARIVAX) for prophylaxis, 0.5 milliliters and Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live lyophilisate and solvent for solution for injection (MMR-II) for prophylaxis, 0.5 milliliters concomitantly (strengths, lot numbers, expiration dates, anatomical locations, schemes and routes of administration not provided). (innapropriate age of vaccine administered). The health care professional could not confirm if any symptomatic events occurred (no adverse event).
MERCK STERILE DILUENT